Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Erasca Inc (NQ: ERAS )

2.780 -0.130 (-4.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Erasca Inc

< Previous 1 2 Next >
Erasca Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Business Updates
From Erasca, Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Over $4 Million Bet On Werewolf Therapeutics? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones closed higher on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday's session saw 16 companies set new 52-week lows. 
Via Benzinga
Erasca to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Erasca, Inc.
Via Globe NewsWire
Erasca Touts Promising Early Data From Lead Cancer Programs
 
Via Benzinga
Red Cat Holdings And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones settled higher by around 175 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
Erasca Announces First Patient Dosed in HERKULES-1 Phase 1b Trial Evaluating ERAS-007 and ERAS-601 MAPKlamp Combination in RAS/MAPK Pathway-Altered Solid Tumors
From Erasca, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Erasca Announces FDA Clearance of IND Application for CNS-Penetrant KRAS G12C Inhibitor ERAS-3490 in KRAS G12C-Mutated Advanced or Metastatic Solid Tumors
ERAS-3490, an orally available small molecule KRAS G12C inhibitor, has demonstrated robust nonclinical CNS and systemic activity 
From Erasca, Inc.
Via Globe NewsWire
RH, HUYA, Bilibili And Some Other Big Stocks Moving Lower On Monday
U.S. stocks traded higher, with the Dow Jones jumping more than 200 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Lululemon, Li Auto, Hackett Group And Some Other Big Stocks Moving Lower On Friday
U.S. stocks traded lower, with the Dow Jones jumping around 70 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Erasca Oulicenses Its Mid-Stage Cancer Program To Novartis, Raises $100M Via Equity Offering
 
Via Benzinga
Erasca Announces Exclusive Worldwide License for Pan-RAF Inhibitor Naporafenib
From Erasca, Inc.
Via Globe NewsWire
Erasca Announces Pricing of Underwritten Offering of Common Stock
From Erasca, Inc.
Via Globe NewsWire
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pierre Fabre to Evaluate ERAS-007 and Encorafenib Combination
From Erasca, Inc.
Via Globe NewsWire
Erasca to Present at Upcoming Investor Conferences
From Erasca, Inc.
Via Globe NewsWire
Erasca Reports Third Quarter 2022 Financial Results and Business Updates
From Erasca, Inc.
Via Globe NewsWire
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 and Palbociclib Combination
From Erasca, Inc.
Via Globe NewsWire
McCormick, Dave & Buster's Entertainment And Other Big Losers From Thursday
U.S. stocks closed higher with the Dow Jones surging around 193 points on Thursday. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to... 
Via Benzinga
US Stocks Flat, Crude Oil Rises 2%
U.S. stocks traded almost flat in volatile trading on Thursday following the release of jobless claims data. 
Via Benzinga
Peering Into Erasca's Recent Short Interest
Erasca's (NASDAQ:ERAS) short percent of float has fallen 17.88% since its last report. The company recently reported that it has 15.10 million shares sold short, which is 19.57%... 
Via Benzinga
Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders. 
Via Benzinga
US Stocks Turn Higher, Nasdaq Jumps 100 Points
U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. 
Via Benzinga
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.